Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cybin Inc
CYBN
Primary Symbol:
N.CYBN
Healthcare
Drug Manufacturers - Specialty & Generic
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary...
deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NEO:CYBN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(4)
•••
Jim1274
X
View Profile
View Bullboard History
Comment by
Jim1274
on Nov 19, 2020 3:50pm
RE:RE:RE:RE:RE:Too Funny...
Cybin is listed on the OTC...CLXPF
(15)
•••
realitycheck00
X
View Profile
View Bullboard History
Comment by
realitycheck00
on Nov 19, 2020 2:30pm
RE:From the situation room.....my take
Agreed and I think a lot of the seed round guys where getting out as well as they would of had a nice return. Yup, markets are unpredictable, lets see what happens and when and if new buying
...more
Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
posted May 03, 2024 9:00am by
Pulsar Helium Inc.
-
|
In recognition of the recent docu-film highlighting the importance of helium in healthcare we are offering investors an opportunity to join Pulsar on the ground in Minnesota for this month's historic reservoir flow tests. CLICK HERE ...read more
(15)
•••
realitycheck00
X
View Profile
View Bullboard History
Post by
realitycheck00
on Nov 19, 2020 2:24pm
Motley Fool Article Compass & Cybin mentioned
Just found this article from Motley Fool on Compass with Cybin mentioned https://www.fool.com/investing/2020/11/18/is-compass-pathways-stock-a-buy/
(66)
•••
88guy88
X
View Profile
View Bullboard History
Post by
88guy88
on Nov 19, 2020 2:15pm
From the situation room.....my take
The big boys and institutions that bought the IPO at 75 cents are holding tight as they see this as an investment and will let it play out over 3 to 5 years The retail investor or flipper bought at
...more
(15)
•••
realitycheck00
X
View Profile
View Bullboard History
Comment by
realitycheck00
on Nov 19, 2020 1:59pm
RE:RE:RE:RE:Too Funny...
Its hard to access the NEO from US folks. They need there OTC listing asap then US investors can come in. Its also probably that seed round investors are selling which is good as a new
...more
(15)
•••
realitycheck00
X
View Profile
View Bullboard History
Comment by
realitycheck00
on Nov 19, 2020 1:54pm
RE:RE:RE:RE:RE:TSX listing would have been better
You probbaly missed a few things such as 2nd most funded company in Canada ($55M raised) next to MindMed which gives them the cash for M&A. Large instituational investorbase from the US some of
...more
(66)
•••
88guy88
X
View Profile
View Bullboard History
Post by
88guy88
on Nov 19, 2020 1:46pm
Unfortunate but likely headed to mid 60's
its a pattern with thin volume
(4)
•••
superzoomer710
X
View Profile
View Bullboard History
Comment by
superzoomer710
on Nov 19, 2020 11:06am
RE:RE:RE:RE:TSX listing would have been better
still having a hard time finding the value . No owned intellectual property….. No apparent paperwork for clinical trials filed….. Sure they may have “dream team” from my observations will
...more
(4)
•••
Jim1274
X
View Profile
View Bullboard History
Comment by
Jim1274
on Nov 18, 2020 10:19pm
RE:RE:RE:TSX listing would have been better
I completely agree with everything, I feel like there's something we don't know? Why the lack of interest? 45m in cash and 100m market cap? That's a steal!! Why is this not moving!!?
(4)
•••
Jim1274
X
View Profile
View Bullboard History
Comment by
Jim1274
on Nov 18, 2020 10:12pm
RE:RE:RE:Too Funny...
Drysdale has stated from day 1 he plans on listing to the Nasdaq but they have to first meet the requirements without siting on too much cash for to long, he was very specific in saying he did not
...more
(4)
•••
Jim1274
X
View Profile
View Bullboard History
Comment by
Jim1274
on Nov 18, 2020 9:55pm
RE:RE:RE:Lot of talented people with connections
What are your thoughts and timelines on the future of this company, I came In full throttle this week and have incredible faith In The team but the lack of interest after going public has me worried..
...more
(15)
•••
realitycheck00
X
View Profile
View Bullboard History
Comment by
realitycheck00
on Nov 18, 2020 3:22pm
RE:Our Study
Good to see progress from all companies as its great for the entire industry! Leaders will deffinately evolve over time. Been holding RVV for some time as well so lets see what catalysts come
...more
(66)
•••
88guy88
X
View Profile
View Bullboard History
Post by
88guy88
on Nov 18, 2020 3:09pm
Our Study
120 people with depression tested with psilocybin strips over 4 month trial in early 2021.....Numinus study is 30 people with additions like smoking and alcohol and this study falls under
...more
(66)
•••
88guy88
X
View Profile
View Bullboard History
Post by
88guy88
on Nov 18, 2020 11:23am
Competition Revive partners with PHRM
noticed today that Revive who has a proprietary thin strip solution (not just Cybin) is working with PHRM for psilocybin research for cancer plus other things like depression the race has started....
...more
(15)
•••
realitycheck00
X
View Profile
View Bullboard History
Comment by
realitycheck00
on Nov 17, 2020 2:36pm
RE:RE:Be wary of bashers
I dont think multi billion dollar biotech funds buy stocks or into companies on hype either. Wonder why they backed Cybin? I guess time will tell.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test